The article in the Salzburger Nachrichten introduces Dr. Daniel Wallerstorfer, CEO and founder of Novogenia GmbH. The company, based in Eugendorf, specializes in genetic analysis and personalized nutritional supplements. Through its brand NovoDaily, Novogenia also offers nutrient blends based on genetic analysis results. To manage growth, Novogenia is planning a €35 million new facility in Hallwang. Production capacity is set to expand, with revenue projected to reach €600 million. Despite automation, the number of employees could increase from 105 to 350.